Sciele receives FDA approvable letter for head lice treatment - Pharmaceutical Business review

17 Jul 2008

Sciele receives FDA approvable letter for head lice treatment

Sciele Pharma, which develops branded prescription products, has announced that the FDA has issued an approvable letter for the head lice treatment.

Sciele Pharma is working closely with Summers Laboratories and the FDA to provide additional information that was requested.

Drug Discovery